Skip to content

Aspire Covered Stent and 718 Delivery System

by Vascular Architects, Inc.

510(k) K031641

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK031641 Date1 Aug 2003ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Vascular Architects Aspire Covered Stent and 718 Delivery System
510(k) Number
FDA Product Code
JCT
Device Class
Class II
Regulation
21 CFR Part 878.3720
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Aspire Covered Stent and 718 Delivery System is a balloon-expandable tracheal prosthesis classified as an expandable tracheal prosthesis. It is designed to maintain luminal diameter in tracheobronchial strictures caused by malignant neoplasms, providing structural support to prevent airway obstruction.

This device is supplied as a single-use, sterile system intended for use in clinical settings such as operating rooms or bronchoscopy suites. The covered stent is delivered via the 718 Delivery System, which is regulated under FDA 510(k) clearance (K031641) and falls under device class II (JCT product code). It is not MRI-safe, and proper storage and handling per manufacturer instructions are required to ensure functionality.

Other devices from Vascular Architects, Inc.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical condition is the Aspire Covered Stent and 718 Delivery System intended to address in patients?

    The Aspire Covered Stent and 718 Delivery System is designed to maintain the tracheobronchial airway lumen in patients with strictures caused by malignant neoplasms. It provides structural support to prevent airway obstruction, helping restore and preserve breathing passages compromised by tumors.

  • Is the Aspire Covered Stent and 718 Delivery System intended for single-use or reusable applications?

    The Aspire Covered Stent and 718 Delivery System is explicitly supplied as a single-use device. This ensures sterility and safety for clinical use in controlled environments like operating rooms or bronchoscopy suites, where it is intended to be deployed once per patient.

  • Can this device be used in patients who require MRI imaging after placement, and why?

    No, the Aspire Covered Stent and 718 Delivery System is not MRI-safe. This means it should not be used in patients who require MRI imaging post-procedure, as the device could pose risks or interfere with MRI compatibility. Always follow manufacturer instructions for storage and handling to maintain functionality.

  • What type of regulatory clearance does the Aspire Covered Stent and 718 Delivery System hold, and how does this affect its use?

    The Aspire Covered Stent and 718 Delivery System holds FDA 510(k) clearance (K031641) under device class II, with a product code of JCT. This clearance indicates it is considered substantially equivalent to a legally marketed predicate device and is regulated under traditional review procedures, ensuring it meets established safety and performance standards for clinical use.